BRPI0917299A2 - aplicação da monooleína como novo lípido adjuvante em lipogecção - Google Patents

aplicação da monooleína como novo lípido adjuvante em lipogecção

Info

Publication number
BRPI0917299A2
BRPI0917299A2 BRPI0917299A BRPI0917299A BRPI0917299A2 BR PI0917299 A2 BRPI0917299 A2 BR PI0917299A2 BR PI0917299 A BRPI0917299 A BR PI0917299A BR PI0917299 A BRPI0917299 A BR PI0917299A BR PI0917299 A2 BRPI0917299 A2 BR PI0917299A2
Authority
BR
Brazil
Prior art keywords
lipogection
monoolein
application
new adjuvant
adjuvant lipid
Prior art date
Application number
BRPI0917299A
Other languages
English (en)
Inventor
Andreia Ferreira Castro Gomes
Joao P N Silva
Margarida Paula Amorim Casal
Maria Elisabete Cunha Dias Real Oliveira
Olga Maria Fernandes Pereira Coutinho
Paulo Jose Gomes Coutinho
Original Assignee
Univ Do Minho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Do Minho filed Critical Univ Do Minho
Publication of BRPI0917299A2 publication Critical patent/BRPI0917299A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0917299A 2008-08-18 2009-08-17 aplicação da monooleína como novo lípido adjuvante em lipogecção BRPI0917299A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT104158A PT104158B (pt) 2008-08-18 2008-08-18 Aplicação da monooleína como novo lípido adjuvante em lipofecção
PCT/IB2009/053619 WO2010020935A2 (pt) 2008-08-18 2009-08-17 Aplicação da monooleína como novo lípido adjuvante em lipofecção

Publications (1)

Publication Number Publication Date
BRPI0917299A2 true BRPI0917299A2 (pt) 2015-11-17

Family

ID=41707522

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917299A BRPI0917299A2 (pt) 2008-08-18 2009-08-17 aplicação da monooleína como novo lípido adjuvante em lipogecção

Country Status (5)

Country Link
US (1) US20110178164A1 (pt)
EP (1) EP2335687B1 (pt)
BR (1) BRPI0917299A2 (pt)
PT (1) PT104158B (pt)
WO (1) WO2010020935A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008141230A1 (en) 2007-05-09 2008-11-20 Lawrence Livermore National Security, Llc Methods and systems for monitoring production of a target protein in a nanolipoprotein particle
US9644038B2 (en) 2011-12-21 2017-05-09 The Regents Of The University Of California Apolipoprotein nanodiscs with telodendrimer
WO2017035326A1 (en) 2015-08-25 2017-03-02 Lawrence Livermore National Security, Llc Stable nanolipoprotein particles and related compositions methods and systems
WO2017044899A1 (en) 2015-09-11 2017-03-16 Lawrence Livermore National Security, Llc Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
CN109843312A (zh) 2016-04-29 2019-06-04 马德里自治大学 用作癌症或免疫失调患者的免疫治疗增效剂或佐剂的包含携带生物活性化合物的脂质体系的制剂
US12083223B2 (en) 2017-05-02 2024-09-10 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions methods and systems for loading RNA
US11207422B2 (en) 2017-05-02 2021-12-28 Lawrence Livermore National Security, Llc MOMP telonanoparticles, and related compositions, methods and systems
AU2020384481B2 (en) 2019-11-12 2025-12-11 Nammi Therapeutics, Inc. Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof
JP7829485B2 (ja) 2019-12-20 2026-03-13 ナミ セラピューティクス, インコーポレイテッド がんの処置において有用なToll様受容体(「TLR」)アゴニストプロドラッグを含有する製剤化および/または共製剤化リポソーム組成物ならびにその方法
WO2025058654A1 (en) 2020-02-19 2025-03-20 Nammi Therapeutics, Inc. Formulated and/or co-formulated liposome compositions containing tgfb antagonist prodrugs useful in the treatment of cancer and methods thereof
WO2021167703A1 (en) 2020-02-19 2021-08-26 Nammi Therapeutics, Inc. Formulated and/or co-formulated liposome compositions containing tgfb antagonist prodrugs useful in the treatment of cancer and methods thereof
KR20230066582A (ko) 2020-09-10 2023-05-16 남미 테라퓨틱스, 인크. 암의 치료에 유용한 pd-1 길항제 전구약물을 함유하는 제제화된 및/또는 공동-제제화된 리포솜 조성물 및 그의 방법
CA3211133A1 (en) 2021-03-18 2022-09-22 Nammi Therapeutics, Inc. Formulated and/or co-formulated liposome compositions containing a2ar antagonist prodrugs useful in the treatment of cancer and methods thereof
US20230226031A1 (en) 2021-11-18 2023-07-20 Nammi Therapeutics, Inc. Formulated and/or Co-Formulated Liposome Compositions Containing Immunogenic Cell Death (ICD) Inducing Prodrugs Useful In The Treatment of Cancer and Methods Thereof
WO2023172347A1 (en) 2022-03-10 2023-09-14 Nammi Therapeutics, Inc. Formulated and/or co-formulated lipid nanocarriers compositions containing toll-like receptor ("tlr") agonist prodrugs useful in the treatment of cancer and methods thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279833A (en) 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5651981A (en) * 1994-03-29 1997-07-29 Northwestern University Cationic phospholipids for transfection
DE59507224D1 (de) * 1994-12-28 1999-12-16 Max Delbrueck Centrum Neues cholesterolderivat für den liposomalen gentransfer
US7001614B2 (en) 1996-08-19 2006-02-21 The United States Of America As Represented By The Department Of Health And Human Services Liposome complexes for increased systemic delivery
US6074667A (en) 1996-11-20 2000-06-13 Kinnunen; Paavo Liposomal transfection method
WO2000030444A1 (en) * 1998-11-25 2000-06-02 Vanderbilt University Cationic liposomes for gene transfer
US6936469B2 (en) 2001-03-22 2005-08-30 Chromos Molecular Systems Inc. Methods for delivering nucleic acid molecules into cells and assessment thereof
AU2002359892A1 (en) 2001-12-31 2003-07-24 Elan Pharmaceuticals, Inc. Efficient nucleic acid encapsulation into medium sized liposomes
US7732420B2 (en) 2003-10-03 2010-06-08 Northwestern University Combinations of transfection lipids exhibiting increased transfection efficiencies
ATE489942T1 (de) * 2004-01-23 2010-12-15 Camurus Ab Ternäre nichtlamellare lipidzusammensetzungen
WO2005118612A1 (en) * 2004-06-04 2005-12-15 Sonus Pharmaceuticals, Inc. Cholesterol/bile acid/bile acid derivative-modified therapeutic anti-cancer drugs

Also Published As

Publication number Publication date
WO2010020935A8 (pt) 2011-03-31
PT104158B (pt) 2011-02-24
US20110178164A1 (en) 2011-07-21
EP2335687B1 (en) 2017-05-24
PT104158A (pt) 2010-02-18
EP2335687A2 (en) 2011-06-22
WO2010020935A2 (pt) 2010-02-25
WO2010020935A3 (pt) 2010-06-17

Similar Documents

Publication Publication Date Title
BRPI0917299A2 (pt) aplicação da monooleína como novo lípido adjuvante em lipogecção
IL290077A (en) Improved lipid formulation
BRPI0914096A2 (pt) método para operar um ventilador e ventilador
BR112012015612A2 (pt) novo derivado de 3-hidróxi-5-arilisotiazol
DK2273984T3 (da) Lipidsammensætning
BRPI1009461A2 (pt) método não invasivo para avaliar a progresão da fibrose hepática
BRPI0923481A2 (pt) laminado para vidro laminado
BRPI1008253A2 (pt) Metoso para tratar biomassa
BR112013014777A2 (pt) método para formar um eletrodo bipolar
FI20106346L (fi) Menetelmä ja sovitelma rakenteen tukemiseksi
EP2309553A4 (en) INTERCONNECTS
EP2504042C0 (en) FABRIC SUPPORT STRUCTURE
BR112012016099A2 (pt) método para formar um substrato
ES1070530Y (es) Expositor dinamico
ES1067680Y (es) Faja para adelgazar
ES1072422Y (es) Toallas con sustentadores incorporados
BRPI0918719A2 (pt) vacina contra nematódeos
ES1071238Y (es) Soporte publicitario
ES1069886Y (es) Soporte publicitario
UA19398S (uk) Рекламний щит
ES1073286Y (es) Aplicador para eliminar el vello
ES1071413Y (es) Pieza soporte para abatir muebles
FI20095760A0 (fi) Tukirakenne
FI20095587L (fi) Tukirakenne
BRPI1015444A2 (pt) método para produzir (+)-zizaeno

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]